Hill-Rom Holdings Inc (HRC) Stock
HRC is no longer traded. Hill-Rom Holdings was acquired by Baxter (BAX) on December 13, 2021.
Each HRC share was exchanged for $156.00 in cash. Prices on this page are historical; the last trade was December 10, 2021 at $155.96.
See Baxter (BAX) stock →Hill-Rom Holdings stock price history
HRC final trading statistics
- Final close
- $155.96
- Final trading day
- Dec 10, 2021
- Market cap at delisting
- $10.30B
- Shares outstanding
- 66.05M
- Final 52-week range
- $93.34 – $156.22
- Avg. volume (final 3 mo.)
- 1,022,432
- All-time high (split-adj.)
- $155.94 · Nov 2021
- All-time low (split-adj.)
- $0.81 · Mar 1980
- Return since IPO
- +17515.4%
- Beta
- 0.55
- Book value / share
- $28.53
- Price / book
- 5.47
Hill-Rom Holdings annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2021 | $3.02B | $248.5M | $6.31 |
| FY2020 | $2.88B | $223.0M | $5.53 |
| FY2019 | $2.91B | $152.2M | $5.08 |
| FY2018 | $2.85B | $252.4M | $4.75 |
| FY2017 | $2.74B | $133.6M | $3.86 |
Last five fiscal years reported before the delisting; fiscal year ending September. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Hill-Rom Holdings Inc
Hill-Rom Holdings, Inc. operates as a medical technology company worldwide. The company operates through Patient Support Systems, Front Line Care, and Surgical Solutions segments. It offers medical surgical beds, intensive care unit beds, and bariatric patient beds, patient mobility solutions, non-invasive therapeutic products and surfaces, and information technologies and software solutions, as well as sells equipment service contracts for its capital equipment. The company also provides patient monitoring and diagnostics products, such as patient exam and diagnostics, patient monitoring, diagnostic cardiology, vision screening, and diagnostics products; and respiratory health products comprising non-invasive devices that provide respiratory support and assist patients in the mobilization of retained blockages. In addition, it offers surgical solutions that include tables, lights, and pendants; and positioning devices for use in shoulder, hip, spinal, and lithotomy surgeries, as well as platform-neutral positioning accessories for operating room tables. Further, the company sells and rents products to acute and extended care facilities through direct sales force and distributors; sells and rents products directly to patients in the home; and sells products to primary care facilities through distributors. Hill-Rom Holdings, Inc. was founded in 1915 and is headquartered in Chicago, Illinois.
Hill-Rom Holdings stock FAQ
What happened to Hill-Rom Holdings stock?
Hill-Rom Holdings was acquired by Baxter (BAX) on December 13, 2021. Shareholders received $156.00 in cash for each share. HRC stock stopped trading on the NYSE, with a final close of $155.96 on December 10, 2021.
What did Hill-Rom Holdings shareholders receive?
Each HRC share was converted into $156.00 in cash. The deal was valued at about $12.5 billion.
Is HRC stock still trading?
No. HRC was delisted from the NYSE on December 13, 2021 and no longer trades on a U.S. exchange.
What was the last price of HRC stock?
HRC closed at $155.96 on its final trading day, December 10, 2021, for a market value of about $10.30B.
What were Hill-Rom Holdings's revenue and earnings in its last full fiscal year?
Hill-Rom Holdings reported revenue of $3.02B and net income of $248.5M in fiscal 2021, its last full year as a public company.
When did Hill-Rom Holdings go public?
Hill-Rom Holdings Inc stock began trading on March 2, 1987.